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Introduction. The Institute of Translational Health Sciences (ITHS) promotes and supports translational research collaboration between clinicians, communities, and
investigators across the five-state Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region. The ITHS has developed a collaborative regional clinical
research network, the Northwest Participant & Clinical Interactions Network (NW PCI), involving 12 diverse clinical health systems and academic institutions.
Methods. This descriptive article details NW PCI’s development, infrastructure and governance, tools, characteristics, and initial outcomes.
Results. Regional NW PCI sites are conducting largely industry-sponsored studies; they are interested in including more grant-funded research. Regional NW PCI sites
had over 1,240 open studies involving over 6700 patients in 2016. NW PCI trials are largely industry-sponsored; NW PCI sites are interested in including more grant-
funded research. In its first three years, the NW PCI Coordinating Center facilitated regional sites’ participation in 34 new grant and contract applications across
diverse topics.
Conclusion. The NW PCI model supports the goals of the developing CTSA Trial Innovation Network by increasing access to cutting-edge research across the
Northwestern U.S., by supporting investigators seeking diverse populations, including those with rare diseases, for their research studies, and by providing settings to
test implementation and dissemination of effective interventions.
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Introduction
To complete the circle of scientific discovery and ensure its translation
into practice, translational investigators must collaborate with
clinicians and healthcare organizations in the community. These
collaborations can inform the entire translational science spectrum,
from identifying health and research priorities, to designing new
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interventions, to developing and testing best practices for imple-
menting interventions in real-world settings [1].
The Clinical and Translational Science Award (CTSA) Program,
funded by the National Center for Advancing Translational Science,
recognizes the importance of these critical community-academic
partnerships, and asks its awardees to demonstrate and support
meaningful engagement with clinicians and healthcare organizations
in translational research [2]. The Institute of Translational Health
Sciences (ITHS) is a CTSA partnership between the University of
Washington (UW), Fred Hutchinson Cancer Research Center, and
Seattle Children’s Hospital & Research Institute. Although the majority
of ITHS services and infrastructure are based in Seattle, Washington,
the ITHS has fostered research collaborations with clinical
and academic institutions, healthcare providers, and community
organizations across the 5-state, Washington, Wyoming, Alaska,
Montana, and Idaho (WWAMI), region. These collaborations build on
the decadeslong relationships that the University of Washington
School of Medicine has established in medical education and clinical
care across the WWAMI region [3–7].
The ITHS has established and grown a Regional Research Collabora-
tions (RRC) Program to promote and support multidirectional trans-
lational research collaboration and exchange between clinicians,
communities, and investigators across the WWAMI region. The RRC
carries out the following:
(1) identifies translational science resources, needs, and priorities of clinical
and academic institutions, investigators, communities, and clinics;
(2) develops trusting research partnerships with institutions, organiza-
tions, communities, clinicians, and investigators committed to
collaborating on translational research;
(3) increases the capacity of investigators, clinicians, and healthcare
institutions to conduct research in community-based settings; and
(4) provides research infrastructure, processes, tools, and guidance
that support translational research in communities and
community-based clinical settings.
The RRC has a regional research liaison, based in the WWAMI region
outside of the Puget Sound metropolitan area, who conducts outreach
to regional organizations and healthcare institutions as one strategy to
meet its aims. Through this outreach, the liaison identified multiple
centers for the conduct of research in health systems outside Seattle
(referred to as regional clinical research centers (CRCs) in this article),
similar to those available in the ITHS-funded, Seattle-based CRCs. Most
of these regional CRCs are sited in large community-based healthcare
systems that include hospitals, primary-care clinics, specialty clinics, and
other health services. The liaison also identified regional CRCs in a rural-
serving primary-care organization, at a regional university, and in a
specialty clinic within a university setting. Some of these health systems
are affiliated with a local university and provide training to medical
professionals. Some serve as tertiary or quarternary referral centers in
their geographical areas. Many conduct not only clinical trials but also
health services research, observational studies, and discovery science.
These regional CRCs are largely conducting industry-sponsored studies;
thus, a great deal of grant-funded research is not benefitting from the
diversity of patients receiving care in these settings.
Several regional CRCs expressed interest in including more
investigator-initiated research in their portfolios, and believed that
there would be potential benefit in forming a network of ITHS-based
and regionally based CRCs committed to the following:
(1) building successful new research collaborations between their
CRCs and university-based investigators;
(2) expanding their capacity for investigator-initiated research; and
(3) ensuring availability of best practices, standard operating
procedures, and training in core competencies for conducting
clinical and health services research in community hospital and
regional research settings.
From these beginnings, the Northwest Participant & Clinical Inter-
actions (NW PCI) Network was born. This article details the NW PCI
Network development process, infrastructure and governance, tools
and resources, and initial characteristics and outcomes, aiming to
inform the developing CTSA Trial Innovation Network as well as
academic medical centers that may want to create similar regional
networks. Development of such networks will increase access for
patients throughout the United States to research studies that can
advance knowledge and improve health.
NW PCI Network
Supporting Network Development
NW PCI was built on the principles of community engagement and
stakeholder involvement. These principles state that stakeholders
and communities must have compelling reasons to be involved in a
particular project (eg, pressing patient or institutional need) and antici-
pate tangible benefits from their participation [8, 9]; partners should be
equal collaborators and recognized and valued for their contributions to
a project [10–12]; and the needs and priorities of community partners
should align with project goals and activities [8, 13].
Faculty and staff from the ITHS’s RRC Program and a leader from the
ITHS’s CRC core initiated this partnership by holding one-on-one
conversations with research administrators and clinical investigators at
CRCs across the region, exploring their successes, interests, needs,
and priorities related to forming a collaborative network that would
leverage existing research infrastructure. The regional CRCs identified
their extensive research infrastructure (eg, Institutional Review
Boards (IRBs), budgeting, contracting, and regulatory monitoring
capabilities and diverse research staff) and efficiencies in conducting
industry-sponsored trials as clear strengths that could support their
goals of involvement in more grant-funded, investigator-initiated
research. These meetings also illuminated variation in the institutional
cultures across regional hospitals and healthcare systems, including
areas such as comfort of clinical providers with involving patients in
research, experience with studies involving special populations such
as infants, children, and the elderly, how to integrate research with
clinical care, and institutional support for conducting research.
The ITHS hosted a meeting of research leaders from these diverse
CRCs across the WWAMI region so that they could share information
about existing research and related services at their respective institu-
tions, discuss research-related challenges, and collectively identify goals
and outcomes for a CRC network. The planning group for the meeting
included regional research leaders as well as ITHS faculty and staff to
ensure that the meeting agenda was responsive to the needs and inter-
ests of the regional partners. Annual meetings sponsored by the ITHS
have become a core mechanism for community-building and supporting
inclusive governance (eg, policy development, research priorities)
among the NW PCI sites and between the sites and the ITHS.
Through this planning and engagement process, the NW PCI Network
was created with an understanding of the similarities and differences
between diverse CRCs, ensuring that the Network’s policies and
procedures support the following aspects:
(1) research studies that align with the priorities of the institutions and
the health needs of their patients;
(2) feasible research protocols that are designed collaboratively with the
sites and minimally interrupt operations in the clinical setting; and
(3) collaborations with regional CRCs as equal partners in the research.
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The result has been a collaborative CRC network involving diverse
clinical and academic institutions (Fig. 1) that increases access to
cutting-edge research across the Northwestern United States,
expands the research capacity of clinical and translational research
centers, and serves as a natural testing environment for research
innovations in real-world settings.
Infrastructure and Governance
The ITHS leadership includes individuals with strong experience in
launching and maintaining clinical research networks (eg, the Cystic
Fibrosis Therapeutics Development Network) and primary-care, practice-
based research networks (ie, the ITHS’s WWAMI region Practice
and Research Network). We drew from these experiences in establishing
the NW PCI’s infrastructure and governance [14–16]. The NW PCI
Network Coordinating Center, comprising 1 faculty member, a network
liaison, and a research scientist from the ITHS RRC Program, is responsible
for network administration, member engagement, and mentorship
and coaching of investigators. The NW PCI Coordinating Center draws
extensively from the expertise of the ITHS’ clinical research resources
and practice-based research units for guidance, tools, and resources [17].
The Coordinating Center is guided by a Steering Committee com-
prising 5 volunteer research leaders from regional NW PCI sites,
3 NW PCI Coordinating Center faculty and staff, 1 ITHS Co-Principal
Investigator who has established and directed a specialty clinical
research network, and the ITHS Operations Director of Clinical
Resources. The Steering Committee meets monthly to vet new sites
and study proposals, develop network policies and procedures, and
discuss issues impacting the NW PCI Network.
Individual NW PCI site champions are vital to the success of the
NW PCI Network. Site champions are administrative or clinical
representatives from member sites who serve as liaisons between the
NW PCI Coordinating Center and the potential research collabora-
tors (eg, Site Principal Investigators) at their institution. They receive
information about study opportunities that have been vetted by the
Steering Committee, determine whether the study might be a good fit
for their institution, and then disseminate the information to clinicians
or other personnel who might be interested in collaborating on the
study. By working directly with the NW PCI Coordinating Center and
representing their institutions at the annual meeting, the site champions
communicate their institutions’ research needs and priorities, develop
and refine network governance, provide research-related information
about their institution, and are active participants in strategic and
operational initiatives.
Institutional support provided by the ITHS has been vital to the
development and maintenance of the NW PCI Network. The ITHS has
supported the NWPCI Coordinating Center and Steering Committee in
developing a strong group of site champions, who identify as collabora-
tive, community-based research leaders and colleagues, and in nurturing
partnerships with investigators and their study teams. Ongoing main-
tenance of the relationships between these individuals and groups is
key to the long-term success of the NW PCI Network in facilitating
collaborative research, developing new pathways for academic-
community partnerships, and mitigating barriers to conducting transla-
tional research in communities and community-based clinical settings.
Tools and Resources
One of the NWPCI’s first projects was the development of tools to better
understand the research infrastructure and experience at NWPCI regional
sites (eg, site curriculum vitae or site “CVs”), as well as sites’ relevant
policies and procedures (eg, study vetting and approval processes), so that
the resources and strengths of the regional CRCs could be communicated
to investigators who might benefit from working with the NW PCI
Network. In addition, we have developed tools and structures through
which to vet and distribute research opportunities to our regional
partners, and ensure quick turnaround times to identify collaborators on
specific grant or contract applications. Together, the tools described in
Table 1 help to ensure that high-quality research is conducted across the
network.
Characteristics and Outcomes
The ITHS has created an innovative collaboration between its 3 CRCs
(the UW Medical CRC, UW Regional Dental CRC, and Seattle
Fig. 1. Map of Northwest Participant and Clinical Interactions Network clinical research center sites.
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Children’s Pediatric CRC) and 10 diverse regional CRCs, and has
demonstrated the capacity of the network for engaging in a full
spectrum of translational research. The 10 regional CRCs serve a
catchment area of over 5.5 million individuals across 9 states, and have
experience with a wide range of clinical and translational research,
including phase 1–4 drug and device trials, and health services
research, with funding from multiple sources (Table 2). These sites
conduct research studies in outpatient and inpatient settings and in
primary and specialty care with patients of all ages. Eight of the
10 regional sites have searchable electronic health record systems. On
average, in 2016, the 10 regional CRCs have roughly 1240 open studies
(range 3–240), involving over 6700 individuals (range 25–2400+).
In its first three years, the NW PCI Coordinating Center facilitated
regional sites’ participation in 34 new grant and contract applications
(2 funded and completed, 7 funded and ongoing, 7 pending, 6 in
development at the time of manuscript submission, 12 not funded), as
well as an internally funded project to identify factors that influence
clinicians’ likelihood of serving as investigators on research studies
(Fig. 2). Completed and ongoing studies have recruited 791 individuals
from NW PCI Network regional sites by the time of manuscript
submission during the same 3 years (1 study involving a comparison
of IRB professionals’ and patients’ views on consent for research
on medical practice has been published [18] and 2 others with
planned manuscripts).
Table 1. Description of Northwest Participant and Clinical Interactions (NW PCI) network operational tools
Tool Description
Mission, vision, and values Forms the foundation for all NW PCI initiatives and studies, and guides the development of NW PCI
Network study criteria and documents, such as the Principles of Collaboration
Principles of Collaboration Outlines the NW PCI Network’s purpose, mission, values, and governance; describes the roles and
responsibilities of the NW PCI Coordinating Center, clinical sites, and research affiliates. Not intended
to be a legal document
Steering Committee Information Sheet Defines roles and responsibilities, composition, and selection criteria and process
Site Curriculum Vitae (CVs) Information about site geographical catchment area, patient demographics, types of clinical and health
services research (eg, drug and device trials, diagnostics development and testing), electronic health
record platform, availability of key research personnel and essential services, and IRB requirements
Site Information Distribution and Privacy Policy Establishes guidelines for distributing identifiable and de-identified information (eg, research capabilities)
about NW PCI sites
Standard Operating Procedures (SOP) matrix Inventory of research-related SOPs by category (eg, investigational products, authorship guidelines,
informed consent) at member sites. Intended to facilitate sharing and standardization of operational
information and identify gaps
Core curriculum matrix for research personnel Inventory of existing training and curriculum by category (eg, records management, research budgets,
responsible conduct of research). Intended to identify gaps and facilitate prioritization of training and
professional development efforts for network sites
Member and Site Champion Contact Form Identifies clinical site champion and champion contact information
NW PCI Network Collaborative Research Study
Development Criteria and Proposal Template
Criteria are used to assess alignment between a proposed study and NW PCI Network goals. Proposal
template is used by investigators to create a 1-page description of the study. Steering Committee
members use the proposal to vet the study, before the proposal is either returned to investigators for
revisions or disseminated to NW PCI site champions
Study vetting and selection process Defines the vetting and approval process used to determine alignment of study proposals with NW PCI
Network goals, and ensures that site champions only receive collaboration opportunities that are
relevant to and feasible within their institutions
Publication policy Defines expectations for the development and authorship of reports and manuscripts
ITHS, Institute of Translational Health Sciences.
Table 2. Characteristics of the 10 regional clinical research centers
Characteristics Description
Affiliated hospitals Thirty hospitals with more than 5800 beds
Geographic catchment
areas
Washington, Wyoming, Alaska, Montana, Idaho, Oregon, North Dakota, South Dakota, and Utah
Research funding All sites receive funding from industry and federal sponsors. Some sites receive funding from private foundations,
as well as local, regional, and state government sponsors
Research capability All sites can conduct outpatient studies. Eight can conduct inpatient studies, 5 can conduct pediatric studies,
and 6 can conduct home-based studies
Electronic health records Eight regional sites have searchable electronic health record systems
Research personnel All network sites have research coordinators and research nurses. Eight have research pharmacists. All sites have
personnel to support contracts, budgets, and general research administration
Institutional Review Boards
(IRBs)
Eight regional sites have experience with or will consider using a centralized IRB process for multisite clinical trials.
Nine regional sites have their own IRBs; 1 site contracts with an IRB at another institution
Types of research All network sites have conducted two or more types of clinical research studies. Types include phase 1-4 clinical trials, investigational
device studies, investigational procedures or methods studies, imaging and/or imaging agent development studies, social behavioral
studies, and health outcomes and/or quality assessment studies
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Investigators working with the NW PCI Network’s regional sites have
come from the 3 core ITHS partner institutions (University of
Washington, Seattle Children’s and Fred Hutchinson Cancer
Research Center), other academic institutions and CTSA programs
(eg, University of Colorado, Stanford University, University of
Wyoming, University of Alabama Birmingham, and Montana State
University), and NW PCI member sites themselves (Fig. 1). These
applications have addressed diverse topics such as laboratory medicine
consultation methods for returning results of complex genomic tests
to clinicians, management of low back pain, patient attitudes toward
randomization to alternate standard-of-care treatments [18], advance
care planning, and predicting care transitions for teens with cerebral
palsy, and have involved different types of clinical and health services
research (eg, care delivery improvement, provider training, drug trials,
comparative effectiveness research). The NW PCI Network is
currently a core resource to the Pacific Northwest Node of the
National Institute on Drug Abuse Clinical Trials Network and a
partner in a master Indefinite Delivery, Indefinite Quantity contract to
the Agency for Healthcare Research and Quality—Accelerating
Change and Transformation in Organizations and Networks
(ACTION III), a model of field-based research designed to promote
innovation in healthcare delivery by accelerating the diffusion of
research into practice, with a focus on patient safety and quality.
Addressing Challenges to Conducting Clinical
and Translational Research in a Distributed
Research Network
Engaging Busy Clinicians in Research
Conducting research in collaboration with the NW PCI Network’s
regional CRCs involves many of the same challenges as research in
university-based settings, such as engaging busy clinicians in research,
recruiting patients, and leveraging electronic health record data
for research [19]. Community-based hospitals and health systems use a
production model to successfully engage clinicians in industry-
sponsored research, supported by personnel who identify relevant
clinical trials, negotiate and implement contracts and budgets, facilitate
centralized human subjects research review, consent, and enroll
patients, and collect data. However, few community-based clinicians
have the protected time needed in investigator-initiated research to
conceptualize and plan research projects, write proposals, lead research
initiatives, direct data analysis, and disseminate findings. Few, if any,
personnel with knowledge about and experience with federal grants
administrationmay be available, and internal IRBsmay have limited or no
experience reviewing novel, investigator-initiated research protocols.
NW PCI’s regional CRCs have highlighted engaging busy clinicians
and their clinical organizations in research as one of their most
significant challenges. Clinicians are more likely to successfully engage
in research if they have protected research time. Without protected
time, the responsibilities of clinical care will take precedence. In most
university-based settings, there is an expectation that clinicians will
participate in research; this is not the case in most of the clinical
institutions hosting NW PCI Network’s regional CRCs. More often,
extraordinary interest and personal commitment to advancing
knowledge and improving patient care are key drivers of research by
clinician investigators at NW PCI’s regional CRCs.
The NW PCI’s Coordinating Center and Steering Committee assess
the potential for synergy between research projects and NW PCI regional
settings as they vet investigators’ proposals, drawing on the priority topic
areas and clinical needs voiced by NW PCI site champions. The NW PCI
Coordinating Center also has identified the subject areas in whichNWPCI
regional sites have active site Principal Investigators (Table 3 and online
Supplementary Material), indicating some of the strengths of NW PCI
regional sites to help link appropriate partners with potential projects.
Fig. 2. Summary of the Northwest Participant and Clinical Interactions Network accomplishments.
Table 3. Top areas of research at Northwest Participant and Clinical Interactions
(NW PCI) regional sites*
Research area
Number of NW PCI sites
with active site PIs (n= 10)
Primary care 8
Cardiovascular
Nursing
Oncology
Pharmacy
7
Healthcare access and disease management 6
Diabetes
Hyperlipidemia
Hypertension
Nutrition and metabolism
Women’s health
5
Behavioral health
Endocrinology
Internal medicine
Neurology
Physical/Occupational therapy
Pulmonology
Stroke
4
PI, Principal Investigators.
*For a complete list of research areas at the NWPCI regional sites, see online
Supplementary Material.
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Primary care, oncology, cardiovascular disease, nursing practice, healthcare
access, and many other specialties are highly active research areas across
the NW PCI Network. Fewer sites are conducting research with special
populations such as infants, children, and the elderly, and this is an area of
planned growth for the Network.
NW PCI Network champions in 7 sites are collaborating on a project
to better understand the interests of primary, specialty, behavioral, and
allied healthcare clinicians in research and the barriers to their involvement
in research at their institutions. Data from this study will inform individual
institutional leaders about the specific barriers to be addressed to
support clinician involvement in research at their sites, and will be com-
piled with data from other participating sites to inform the development
of a testable intervention to increase clinician engagement in research.
Minimizing Regional Site Burden During the Pre-Award
Process
The NW PCI Coordinating Center has developed systems that minimize
effort by the regional sites in grant submissions to avoid burdening them
with excessive paperwork. By using processes and tools outlined in
Table 1, the NW PCI Coordinating Center assists in developing standard
budgets, budget justifications, scopes of work, and letters of support,
which helps to ensure standardization of these documents for studies
involving multiple collaborators, and in gaining economies of scale.
A related challenge is maintaining regional sites’ enthusiasm for colla-
borative research efforts given a national success rate of less than 20%
[20] for investigator-initiated research grant proposals to the NIH.
Minimizing the clinical site burden may enable NW PCI regional sites
to consider a higher volume of proposals than would be possible if
each site had to develop its own grant application materials.
Program Sustainability
The NW PCI Coordinating Center has determined the costs of
maintaining the NW PCI Network infrastructure so that it can recover
some of these costs through a “Network User Fee” that is leveraged
to investigators annually in grant applications. This fee helps offset
infrastructure costs for activities such as NW PCI Network meetings
(eg, annual, Steering Committee, and Coordinating Center meetings),
time spent developing policies and procedures, general marketing and
communications, recruiting new members, compiling site information,
and conducting site visits.
Training and Mentoring Investigators and Regional Site
Personnel
Preparing investigators new to community-based research involves
training in the principles of community engagement, as well as dis-
semination and implementation science, and mentoring to be effective
collaborators with NW PCI Network regional sites. The NW PCI
Coordinating Center draws upon the expertise of experienced faculty
to guide the alignment of investigators’ research aimswith the health and
research priorities of their community-based collaborators, a network
coordinator to assist with the development of the scope of work and
operability of their studies, and a research scientist experienced in
community-engaged research to consult with investigators, and ensure
consistent communications and focus on milestones. Emphasizing the
use of standard operational procedures, document templates, and other
tools enables the faculty and staff in the NW PCI Coordinating Center
to scale up efforts to train and mentor more investigators.
Regional site personnel such as clinicians, hospital administrators, and
research personnel also require training specific to their research
roles, the type of funding sought, and the desired level of research
independence. One NW PCI regional site organized available, online
ITHS educational seminars and other materials into role-specific
training modules for investigators, nurses, research associates, regu-
latory personnel, and business operations staff. Personnel in
each category have lists of required, optional, and secondary topics.
Information about the training modules has been made available to all
NW PCI sites, and it is available to others upon request.
Some NWPCI regional sites seek to develop new, independent clinical
investigators who can successfully compete for research funding,
which requires training in grantsmanship, study design, federal grant
administration, and other topics typical of early-career investigator
training. The NW PCI Coordinating Center works with NW PCI
regional sites collectively and individually to identify training needs
and facilitate access to workforce development opportunities.
Conclusions
The ITHS’ commitment to (1) learning about the translational research
resources, strengths, and needs across the 5-state, WWAMI region
and (2) collaborating with regional investigators and clinical institutions
led us to the discovery of a diverse pool of healthcare organizations
and their clinical research units eager to collaborate on research. The
research-related experience, skills, and capacity of these ITHS partners
that have been amassed through the conduct of largely sponsored
clinical trials translate readily to investigator-initiated clinical, transla-
tional, and health services research.
Access to clinical trials is often limited for patients distant from
university-based medical centers. For example, less than 1 in 1000
individuals, 800 of whom experience symptoms on a monthly basis,
will be admitted to a university-based medical center [21]. The
National Cancer Institute (NCI), National Clinical Trials Network [22]
conducts large-scale clinical trials and enrolls patients via 30 “Lead
Academic Participating Sites” and a newly developed NCI Community
Oncology Research Program (NCORP) of community hospitals and
medical centers. In its first year, the NCI Community Oncology
Research Program reported enrolling 25% of all patients involved in
NCI National Clinical Trials Network studies [23]. Four of the 5 states
in theWWAMI region do not have their own university-based medical
centers, and access to clinical trials is an issue of national concern.
A network such as NW PCI provides more opportunities for patients,
regardless of their residence location, to access clinical trials as well as
other research studies. It could also provide access for investigators of
rare diseases to tap into heretofore hard-to-reach populations to
recruit adequately for their trials.
The ITHS and its NW PCI Network Coordinating Center and Steering
Committee have developed tools, procedures, policies, structures,
and materials to support CTSA programs and institutions nationally in
implementing and maintaining similar networks (www.iths.org and
available upon request). NW PCI’s strong research capability in real-
world settings, representative of where the majority of Americans
receive their care, is a model that supports the goals of the developing
CTSA Trial Innovation Network. The NW PCI Network is an
important research resource for the CTSA Consortium and for
investigators seeking diverse populations for their clinical and
health services research, adequate numbers of individuals with rare
diseases, and settings to test implementation and dissemination of
effective interventions.
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